CliffBio
small molecule

TOPICORT

DESOXIMETASONE

Loss of exclusivitySeptember 2028latest FDA-listed patent expiry
CompanySUN PHARMA CANADA INC

Drug detail

Brand nameTOPICORT
Active ingredientDESOXIMETASONE
Strength0.25%
Dosage formSPRAY
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 2013
Marketing statusRX

Listed patents

PatentExpiresType
8277780September 2028product
8715624May 2026product

More from SUN PHARMA CANADA INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TOPICORT patent cliff — loss of exclusivity September 2028 | CliffBio